Matthew Pillar

Matthew Pillar is chief editor at BioProcess Online. He's spent the past 20 years covering tech-centric industries as they’ve navigated AI, machine learning, IoT, and other emerging technologies. His chief and executive editorial experience includes tenures with Software Executive, Channel Executive, Business Solutions and ISR magazines, where he routinely interviewed international technology builders and influencers. Pillar has spoken on emerging technologies and their implications at major events for leading tech vendors including NetSuite, Oracle, SAP, and others.

Connect with Pillar on LinkedIn at linkedin.com/in/matthewpillar/

ARTICLES BY MATTHEW PILLAR

The Real Threat To Biopharma Supply Chains: Bioprocessing Materials
ILC Therapeutics’ Interferon Alpha 14 Joins The COVID-19 Fight
Santiago: Leading The Chilean Biotech Revolution
New Podcast: Building Blocks Of The Biopharma Business
Introducing The Business Of Biotech Podcast
Data Intelligence And Biopharma’s COVID-19 Responsibility
Nurturing A Nascent Colorado Biotech Hub
Inside FDA’s AI-Based Established Conditions Pilot
New FDA Guidance For Clinical Trials Disrupted By COVID-19
Virus Exposes Weak Links In The Biopharma Supply Chain
Is Biopharma’s Response To Coronavirus Off The Mark?
Nurturing A Nascent Colorado Biotech Hub
COVID-19: A Case For “Virtual” Biopharma?
The Process Behind The Potential: Therapy For HPV16-Related Malignancies
Update On Advanced Rapid Microbiology Methods In Biopharma
The Perilous Development Of A Potential Biologic Blockbuster
CDER-ETP: A Resource For Innovative Biopharma Firms
A Disruptive Approach To Oncology Therapy Development
How BlueWillow Biologics Is Pioneering Mucosal Vaccine Tech
Alternative Funding For Startup Biotechs
International Reference Pricing: The Answer To Rising Drug Costs?
Early-Stage Biopharma Funding Advice From A Leading VC
How The Medical Innovation Act Could Stifle Medical Innovation
Outsourcing Insights From A Tech Transfer Veteran
Solving Pharma’s Public Opinion Crisis